PULMER JACK PULIDO: Open Payments
NPI 1578256228 · LONG BEACH, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,172 in 54 payments from 7 companies in 2025. Trend: 2023 $703 · 2024 $1,077 · 2025 $2,172
Food & beverage: $2,071Education: $101
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 10 | $556 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $521 |
| Teva Pharmaceuticals USA, Inc. | 8 | $408 |
| Janssen Pharmaceuticals, Inc | 14 | $393 |
| Otsuka America Pharmaceutical, Inc. | 7 | $136 |
| E.R. Squibb & Sons, L.L.C. | 3 | $135 |
| ABBVIE INC. | 1 | $22 |
Products named: CAPLYTA, INVEGA SUSTENNA, ARISTADA, LYBALVI, UZEDY, COBENFY, AUSTEDO XR, REXULTI.
Industry payments across CA — which companies pay providers there.
